Professor Raymond Reilly, founder of the Centre for Pharmaceutical Oncology, works alongside PhD student Valerie Facca at the Leslie Dan Faculty of Pharmacy.
Imagine a future without cancer. Led by the Union for International Cancer Control (UICC), World Cancer Day aims to save millions of preventable deaths each year by raising awareness and education about cancer, and pressing governments and individuals across the world to take action against the disease.
Stéphane Angers, associate dean of research at the Leslie Dan Faculty of Pharmacy is buoyed by the many recent advances in research. “We understand the biology of cancer in ways we never did before,” says Angers whose research group specializes in using CRISPR-Cas9 technologies to screen cancer stem cells and characterize the genes that are essential for tumor growth. “This has led to genuinely promising new categories of treatment including a new therapeutic antibody for pancreatic cancer that will soon enter human clinical trial.”
"We understand the biology of cancer in ways we never did before"
The Centre for Pharmaceutical Oncology (CPO) at the Leslie Dan Faculty of Pharmacy aims to bridge the gap between research discoveries in cancer biology and the development of new molecular diagnostics and therapeutics for cancer and their advancement to first-in-humans clinical trials.
Raymond Reilly, pharmaceutical oncology scientist and Director of the CPO notes that the Centre has assembled more than 170 scientists and trainees to focus their combined skills and efforts on improving the outcome of cancer patients. Research in the CPO is driven by the need to find better ways to detect cancer, select patients for personalized therapies, and develop new molecularly targeted treatments, especially for the most difficult to treat cancers such as pancreatic cancer, metastatic breast cancer and glioblastoma, a type of brain tumour.
“I envision a future in which almost every cancer will be treatable and curable, since through research we will have discovered the treatments that are needed to achieve this great outcome” said Reilly.
Leslie Dan Faculty of Pharmacy Cancer Research Highlights of 2019
Shining a Spotlight On Cancer Cells
Leslie Dan Faculty of Pharmacy professor Christine Allen designs nanotechnologies to help surgeons identify tumours.
More News
Image
![Celene Titus, PhD candidate Celene Titus, PhD candidate](/sites/default/files/styles/landscape_4_3_600/public/images/2024-07/celene_titus_featured.jpg?itok=5zflGERW)
Faces of PharmSci: Celene Titus
PhD student Celene Titus is working in the field of HIV-Associated Neurocognitive Impairments (NCI) and brain inflammation to improve HIV patients' quality of life and deepen our understanding of brain inflammation in HIV infection.
Read More
Image
![Darius Rackus, Molly Shoichet, and Gilbert Walker Darius Rackus, Molly Shoichet, and Gilbert Walker](/sites/default/files/styles/landscape_4_3_600/public/images/2024-07/biohubnet_featured.jpg?itok=TL8QwP6W)
BioHubNet set to bridge academia and industry to strengthen Canada’s biomanufacturing talent pipeline
To kick-off the new launched Biomanufacturing Hub Network (BioHubNet) initiative, partners and collaborators met at U of T's Hart House to address key challenges in Canada's biomanufacturing sector.
Read More
Image
![Graduate Research in Progress (2024) Committee Graduate Research in Progress (2024) Committee](/sites/default/files/styles/landscape_4_3_600/public/images/2024-06/grip_2024_featured.jpg?itok=UZygswBz)
Exploring Tomorrow's Breakthroughs: GRIP 2024
Last week, the Leslie Dan Faculty of Pharmacy hosted its 2024 GRIP symposium, attended by 200 faculty, staff, and students, showcasing diverse graduate student research.
Read More